Gomaa_2022_Eur.J.Pharmacol__174873

Reference

Title : Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia - Gomaa_2022_Eur.J.Pharmacol__174873
Author(s) : Gomaa AA , Farghaly HSM , Ahmed AM , El-Mokhtar MA , Hemida FK
Ref : European Journal of Pharmacology , :174873 , 2022
Abstract : Gomaa_2022_Eur.J.Pharmacol__174873
ESTHER : Gomaa_2022_Eur.J.Pharmacol__174873
PubMedSearch : Gomaa_2022_Eur.J.Pharmacol__174873
PubMedID: 35283111

Related information

Citations formats

Gomaa AA, Farghaly HSM, Ahmed AM, El-Mokhtar MA, Hemida FK (2022)
Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia
European Journal of Pharmacology :174873

Gomaa AA, Farghaly HSM, Ahmed AM, El-Mokhtar MA, Hemida FK (2022)
European Journal of Pharmacology :174873